Evidence map›Paper›PMID 30271901›Full record

ArticleCommunications biology2018

A rare missense variant in

Aimee M Deaton, Patrick Sulem, Paul Nioi, Stefania Benonisdottir, Lucas D Ward, Olafur B Davidsson, Socheata Lao, Anna Helgadottir, Fan Fan, Brynjar O Jensson and 22 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Lipids: Driving Forces in the Underlying Biology of Carcinogenesis.ACS pharmacology & translational science · 2025
    Review
  2. Bile acid metabolism in type 2 diabetes mellitus.Nature reviews. Endocrinology · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 3 institutions in 1 country.

Aimee M DeatondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Patrick SulemdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland. patrick.sulem@decode.is.ORCID http://orcid.org/0000-0001-7123-6123
Paul NioideCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Stefania BenonisdottirdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Lucas D WarddeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.ORCID http://orcid.org/0000-0002-8017-809X
Olafur B DavidssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Socheata LaodeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Anna HelgadottirdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Fan FandeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Brynjar O JenssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Gudmundur L NorddahldeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Aslaug JonasdottirdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Adalbjorg JonasdottirdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Asgeir SigurdssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Ragnar P KristjanssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Asmundur OddssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
Gudny A ArnadottirdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.ORCID http://orcid.org/0000-0001-6571-423X
Hakon JonssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Isleifur OlafssonDepartment of Clinical Biochemistry, Landspitali University Hospital, Reykjavik, 101, Iceland.
Gudmundur I EyjolfssonLaboratory in Mjódd (RAM), Reykjavik, 109, Iceland.
Olof SigurdardottirDepartment of Clinical Biochemistry, Akureyri Hospital, Akureyri, 600, Iceland.
Einar S BjornssonFaculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
Sigurdur OlafssonFaculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
Thora SteingrimsdottirFaculty of Medicine, University of Iceland, Reykjavik, 101, Iceland.
Thorunn RafnardeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Gudmundur ThorgeirssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Gisli MassondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Gudmar ThorleifssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Daniel F GudbjartssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Hilma HolmdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Unnur ThorsteinsdottirdeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland.
Kari StefanssondeCODE Genetics/Amgen, Inc., Reykjavik, 101, Iceland. kstefans@decode.is.
deCODE Genetics (Iceland) · ISReykjavík University · ISAkureyri Hospital · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Searching for novel sequence variants associated with cholesterol levels is of particular interest due to the causative role of non-HDL cholesterol levels in cardiovascular disease. Through whole-genome sequencing of 15,220 Icelanders and imputation of the variants identified, we discovered a rare missense variant in

Identifiers

PMID30271901
PMCPMC6123719
OpenAlexW2805444314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.